Share the post "Shareholding Pattern: Shareholding Pattern Advanced Enzyme Technologies FY(Q1-Jun 2024-2025)"
Advanced Enzyme Technologies has released its latest shareholding reports, covering the quarter and the first half of the fiscal year ending on (Q1-Jun 2024-2024).This detailed report examines who owns shares, including Promoters, promoter groups, Foreign investors, public investors, and government entities.
Shareholder Name | Previous Quater Quantity(In Crores) | Current Quater Quantity(In Crores) | Previous Quater Shares(in %) | Current Quater Shares(in %) | Quater to Quater Difference |
---|---|---|---|---|---|
Promoters | 4.86 | 4.81 | 43.49 | 43.02 | -0.47 % |
Public | 6.32 | 6.37 | 25.94 | 36.87 | +10.93 % |
DII | 0.85 | 0.90 | 7.56 | 8.08 | +0.52 % |
FII | 2.57 | 1.34 | 23.01 | 12.03 | -10.98 % |
Government | 0 | 0 | 0 | 0 | 0 |
Promoters’ shareholding decreased from 43.49% in March 2024 to 43.02% in June 2024. This reduction indicates that the promoters’ control over Company has weakened during this period.The percentage of shares held by the public increased from 25.94% in March 2024 to 36.87% in June 2024.This change suggests that the public’s investment in the company grew during the quarter.DIIs (Domestic Institutional Investors) shareholding increased from 7.56% in March 2024 to 8.08% in June 2024 , indicating that domestic institutions increased their stake in the company by 0.52% . FIIs (Foreign Institutional Investors) shareholding decreased from 23.01% in March 2024 to 12.03% in June 2024 ,indicating that foreign institutions reduced their investments by 1.5% in the company during the quarter. This suggests a pullback in their investment .
Let’s look into the statistics of the investors, which could have contributed to the fluctuations in the shareholding pattern.
Shareholder Name | Previous Quarter Quantity (In crores) | Current Quarter Quantity (In crores) | Previous Quarter Shares (in %) | Current Quarter Shares (in %) | Quarter-to-Quarter Difference (%) |
---|---|---|---|---|---|
Chandrakumar Laxminarayan Rathi | 0.005 | 0.000 | 0.04 | 0 | -0.04 % |
Advanced Vital Enzymes Pvt Ltd | 0.049 | 0.000 | 0.44 | 0 | -0.44 % |
Chandrakumar Laxminarayan Rathi faced a downturn in stakeholding this quarter, witnessing a decline of -0.04 % in stakeholding compared to the previous quarter.Advanced Vital Enzymes Pvt Ltd faced a downturn in stakeholding this quarter, witnessing a decline of -0.44 % in stakeholding compared to the previous quarter.
Shareholder Name | Previous Quarter Quantity (In Crores) | Current Quarter Quantity (In Crores) | Previous Quater Shares (in %) | Current Quater Shares (in %) | Quater-to-Quater Difference (%) |
---|---|---|---|---|---|
Resident Individuals holding nominal share capital up to Rs. 2 lakhs | 1.642 | 1.730 | 14.68 | 15.48 | + 0.8 % |
Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs | 0.083 | 0.106 | 0.75 | 0.94 | + 0.19 % |
Non Resident Indians (NRIs) | 0.400 | 0.419 | 3.58 | 3.75 | + 0.17 % |
Pradip Bhailal Shah | 0.202 | 0.202 | 1.81 | 1.8 | -0.01 % |
Foreign Companies | 0.246 | 1.351 | 2.2 | 12.08 | + 9.88 % |
Orbimed Asia III Mauritius FVCI Limited | 0.246 | 1.351 | 2.2 | 12.08 | + 9.88 % |
Bodies Corporate | 0.107 | 0.116 | 0.96 | 1.03 | + 0.07 % |
Any Other (specify) | 0.160 | 0.139 | 1.43 | 1.24 | -0.19 % |
HUF | 0.053 | 0.053 | 0.47 | 0.48 | + 0.01 % |
Trusts | 0.077 | 0.055 | 0.69 | 0.49 | -0.2 % |
Leading the way to higher stakeholding, Resident Individuals holding nominal share capital up to Rs. 2 lakhs has significantly boosted stakeholding by an impressive 0.8 %.Leading the way to higher stakeholding, Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs has significantly boosted stakeholding by an impressive 0.19 %.Leading the way to higher stakeholding, Non Resident Indians (NRIs) has significantly boosted stakeholding by an impressive 0.17 %.Observations show a significant difference of -0.01 % in Pradip Bhailal Shah’s financial performance between quarters.Leading the way to higher stakeholding, Foreign Companies has significantly boosted stakeholding by an impressive 9.88 %.Leading the way to higher stakeholding, Orbimed Asia III Mauritius FVCI Limited has significantly boosted stakeholding by an impressive 9.88 %.Leading the way to higher stakeholding, Bodies Corporate has significantly boosted stakeholding by an impressive 0.07 %.Observations show a significant difference of -0.19 % in Any Other (specify)’s financial performance between quarters.Leading the way to higher stakeholding, HUF has significantly boosted stakeholding by an impressive 0.01 %.Observations show a significant difference of -0.2 % in Trusts’s financial performance between quarters.
Shareholder Name | Previous Quarter Quantity (In Crores) | Current Quarter Quantity (In Crores) | Previous Quater Shares (in %) | Current Quater Shares (in %) | Quater-to-Quater Difference (%) |
---|---|---|---|---|---|
Mutual Funds/ | 0.615 | 0.650 | 5.5 | 5.82 | + 0.32 % |
ICICI Prudential ESG Fund | 0.197 | 0.170 | 1.77 | 1.52 | -0.25 % |
HDFC Small Cap Fund | 0.410 | 0.373 | 3.67 | 3.33 | -0.34 % |
Alternate Investment Funds | 0.230 | 0.253 | 2.06 | 2.26 | + 0.2 % |
Clarus Capital I | 0.143 | 0.169 | 1.28 | 1.51 | + 0.23 % |
The latest quarter saw a considerable enhancement in stakeholding for Mutual Funds/, reflecting an uptick of 0.32 % in their shares.ICICI Prudential ESG Fund decreased their stake from 1.52% in the previous quarter to 1.77% in the current quarter.It describes a decrease in stakes over consecutive quarters, specifically by -0.25 %.HDFC Small Cap Fund decreased their stake from 3.33% in the previous quarter to 3.67% in the current quarter.It describes a decrease in stakes over consecutive quarters, specifically by -0.34 %.The latest quarter saw a considerable enhancement in stakeholding for Alternate Investment Funds, reflecting an uptick of 0.2 % in their shares.The latest quarter saw a considerable enhancement in stakeholding for Clarus Capital I, reflecting an uptick of 0.23 % in their shares.
Shareholder Name | Previous Quarter Quantity (In Crores) | Current Quarter Quantity (In Crores) | Previous Quater Shares (in %) | Current Quater Shares (in %) | Quater-to-Quater Difference (%) |
---|---|---|---|---|---|
Foreign Portfolio Investors Category I | 2.416 | 1.226 | 21.61 | 10.97 | -10.64 % |
Nalanda India Equity Fund Limited | 0.996 | 0.947 | 8.91 | 8.46 | -0.45 % |
Foreign Portfolio Investors Category II | 0.157 | 0.118 | 1.4 | 1.06 | -0.34 % |
Orbimed Asia III Mauritius Limited | 1.105 | 0 | 9.88 | 0 | -9.88% |
Stakeholding dwindled by -10.64 % for Foreign Portfolio Investors Category I in comparison to the preceding quarter.Stakeholding dwindled by -0.45 % for Nalanda India Equity Fund Limited in comparison to the preceding quarter.Stakeholding dwindled by -0.34 % for Foreign Portfolio Investors Category II in comparison to the preceding quarter.Orbimed Asia III Mauritius Limited had 9.88% of shares in the previous quarter but exited in the current quarter.
[my_shortcode1 values=”Advanced Enzyme Technologies “]